Furthermore, studies have implicated H3K36me3 in alternative splicing in human cell culture (Luco et al., 2010; Pradeepa et al., 2012) and inefficient intron splicing in clear cell renal cell carcinomas (Simon et al., 2014), again via SETD2 mutation. This evidence concerns the gene SETD2 and clear cell renal carcinoma.